HK1076816A1 - - Google Patents
Info
- Publication number
- HK1076816A1 HK1076816A1 HK05111431.9A HK05111431A HK1076816A1 HK 1076816 A1 HK1076816 A1 HK 1076816A1 HK 05111431 A HK05111431 A HK 05111431A HK 1076816 A1 HK1076816 A1 HK 1076816A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- chem
- pharmaceutically acceptable
- general formula
- acceptable salt
- active ingredient
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002365927 | 2002-12-17 | ||
| JP2003363820 | 2003-10-23 | ||
| PCT/JP2003/016131 WO2004054989A1 (ja) | 2002-12-17 | 2003-12-16 | 新規２，４−ジアミノ−１，３，５−トリアジン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1076816A1 true HK1076816A1 (de) | 2006-01-27 |
Family
ID=32599275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05111431.9A HK1076816A1 (de) | 2002-12-17 | 2005-12-12 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7622469B2 (de) |
| EP (1) | EP1574503B1 (de) |
| JP (1) | JP4391422B2 (de) |
| KR (1) | KR101027366B1 (de) |
| AU (1) | AU2003289375A1 (de) |
| BR (1) | BRPI0317188A8 (de) |
| CA (1) | CA2510468C (de) |
| ES (1) | ES2403141T3 (de) |
| HK (1) | HK1076816A1 (de) |
| MX (1) | MXPA05006450A (de) |
| NZ (1) | NZ540972A (de) |
| WO (1) | WO2004054989A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4859922B2 (ja) * | 2005-06-14 | 2012-01-25 | シェーリング コーポレイション | アスパルチルプロテアーゼ阻害剤としての化合物の調製および使用 |
| FR2896161B1 (fr) * | 2006-01-13 | 2008-04-04 | Merck Sante Soc Par Actions Si | Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique. |
| DE102007054416A1 (de) * | 2007-11-13 | 2009-05-14 | Studiengesellschaft Kohle Mbh | Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind |
| DE102008007314A1 (de) | 2008-02-02 | 2009-08-06 | Merck Patent Gmbh | Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten |
| EA018921B1 (ru) * | 2008-05-23 | 2013-11-29 | Поксел Сас | Способ синтеза производных 3,6-дигидро-1,3,5-триазина |
| WO2010024225A1 (ja) | 2008-08-25 | 2010-03-04 | 浜理薬品工業株式会社 | 新規ジヒドロトリアジン誘導体 |
| US11465989B2 (en) | 2014-04-17 | 2022-10-11 | ImmunoMet Therapeutics, Inc. | Guanidine compounds and use thereof |
| KR102216701B1 (ko) | 2014-11-20 | 2021-02-18 | 이뮤노메트테라퓨틱스 인코포레이티드 | 바이구아나이드 화합물 및 이의 용도 |
| DE102018220631A1 (de) * | 2018-11-29 | 2020-06-04 | B. Braun Melsungen Ag | Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden |
| DE102018220624A1 (de) | 2018-11-29 | 2020-06-04 | B. Braun Melsungen Ag | Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden |
| CN112642410A (zh) * | 2020-12-01 | 2021-04-13 | 中国工程物理研究院核物理与化学研究所 | 一种用于水体中铀提取的抗菌聚合物纤维及其制备方法 |
| DE102023201126A1 (de) | 2023-02-10 | 2024-08-14 | B. Braun Melsungen Aktiengesellschaft | Dihydrotriazinverbindung sowie Zusammensetzung zur Anwendung in der Podologie, bei der Prophylaxe und/oder Behandlung von Fußerkrankungen, der Behandlung von Tätowierungen und/oder Tätowierungswunden sowie der Behandlung eines Piercings und/oder von Piercing-Wunden |
| DE102023201127A1 (de) | 2023-02-10 | 2024-08-14 | B. Braun Melsungen Aktiengesellschaft | Medizinprodukt und Verfahren zur Herstellung des Medizinprodukts |
| DE102023201122A1 (de) | 2023-02-10 | 2024-08-14 | B. Braun Melsungen Aktiengesellschaft | Antimikrobiell wirksames Produkt |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3168519A (en) | 1961-10-17 | 1965-02-02 | American Cyanamid Co | 1-alkylphenyl-2, 2-di lower alkyl-4, 6-diimino-hexahydro-s-triazines |
| US3287365A (en) | 1963-12-24 | 1966-11-22 | American Cyanamid Co | Novel dihydro-s-triazines and method of preparation |
| US3287366A (en) * | 1963-12-24 | 1966-11-22 | American Cyanamid Co | Novel 1, 2-dihydro-s-triazines |
| DE1620178A1 (de) * | 1965-12-03 | 1970-03-12 | Ruhrchemie Ag | Verfahren zur Herstellung von Aminoalkylamino-s-triazinen |
| JPS4541591B1 (de) * | 1967-12-11 | 1970-12-26 | ||
| US5565451A (en) * | 1994-09-15 | 1996-10-15 | Fmc Corporation | 1-substituted-2, 4-diamino-6, 6-dialkyl-1, 6-dihydro-1, 3, 5-triazines as insecticides |
| WO1999001442A1 (en) | 1997-07-02 | 1999-01-14 | Zeneca Limited | Triazine derivatives and their use as antibacterial agents |
| ES2249045T3 (es) * | 1998-12-01 | 2006-03-16 | Bayer Cropscience K.K. | 1,3,5-triazinas sustituidas como herbicidas. |
| FR2804113B1 (fr) | 2000-01-26 | 2004-06-18 | Lipha | Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique |
| US7893096B2 (en) * | 2003-03-28 | 2011-02-22 | Novartis Vaccines And Diagnostics, Inc. | Use of small molecule compounds for immunopotentiation |
-
2003
- 2003-12-16 EP EP03780808A patent/EP1574503B1/de not_active Expired - Lifetime
- 2003-12-16 CA CA2510468A patent/CA2510468C/en not_active Expired - Lifetime
- 2003-12-16 ES ES03780808T patent/ES2403141T3/es not_active Expired - Lifetime
- 2003-12-16 US US10/539,234 patent/US7622469B2/en not_active Expired - Lifetime
- 2003-12-16 JP JP2004560647A patent/JP4391422B2/ja not_active Expired - Fee Related
- 2003-12-16 AU AU2003289375A patent/AU2003289375A1/en not_active Abandoned
- 2003-12-16 BR BRPI0317188A patent/BRPI0317188A8/pt not_active Application Discontinuation
- 2003-12-16 MX MXPA05006450A patent/MXPA05006450A/es active IP Right Grant
- 2003-12-16 NZ NZ540972A patent/NZ540972A/xx not_active IP Right Cessation
- 2003-12-16 KR KR1020057011197A patent/KR101027366B1/ko active IP Right Grant
- 2003-12-16 WO PCT/JP2003/016131 patent/WO2004054989A1/ja active Application Filing
-
2005
- 2005-12-12 HK HK05111431.9A patent/HK1076816A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2510468C (en) | 2011-01-04 |
| BRPI0317188A2 (pt) | 2005-11-01 |
| US20060154928A1 (en) | 2006-07-13 |
| WO2004054989A1 (ja) | 2004-07-01 |
| JP4391422B2 (ja) | 2009-12-24 |
| KR20050085720A (ko) | 2005-08-29 |
| NZ540972A (en) | 2009-03-31 |
| EP1574503A4 (de) | 2008-06-25 |
| AU2003289375A1 (en) | 2004-07-09 |
| ES2403141T8 (es) | 2013-06-21 |
| EP1574503B1 (de) | 2013-03-13 |
| ES2403141T3 (es) | 2013-05-14 |
| EP1574503A1 (de) | 2005-09-14 |
| KR101027366B1 (ko) | 2011-04-11 |
| CA2510468A1 (en) | 2004-07-01 |
| US7622469B2 (en) | 2009-11-24 |
| MXPA05006450A (es) | 2005-08-19 |
| JPWO2004054989A1 (ja) | 2006-04-20 |
| BRPI0317188A8 (pt) | 2018-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
| RS24604A (en) | Herbicides containing substituted thien- 3-yl-sulfonylamino (thio)carbonyl- triazolin(thi)one | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| WO2005046589A3 (en) | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties | |
| EP1704856A4 (de) | Proteininhibitor der hsp90-familie | |
| IL157254A0 (en) | N-substituted nonaryl-heterocyclic nmda/mr2b antagonists | |
| WO2006113552A3 (en) | Cyanoarylamines | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| EP1314712A4 (de) | Substituierte benzoesäurederivate als nf-kappa-b-inhibitoren | |
| HK1076816A1 (de) | ||
| DE69920923D1 (de) | Anthranilsäurederivate | |
| IL169184A0 (en) | Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents | |
| EP1026162A4 (de) | Antirheumatika | |
| HK1064673A1 (en) | Fused-polycyclic compounds | |
| MXPA05011521A (es) | Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo. | |
| NO20070421L (no) | Radiosensitiviserende middel | |
| WO2005035528A3 (en) | Triazole derivatives as antibacterial agents | |
| TW200420561A (en) | Antimicrobial 1-aryl dihydropyridone compounds | |
| WO2003086412A3 (fr) | Derives poly-phosphonates pour compositions dentifrices | |
| EP1557407A4 (de) | Neue alpha-ketoamidderivate und deren verwendung | |
| MXPA05009243A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados. | |
| DE60325172D1 (de) | Verbindungen als semaphorininhibitoren | |
| DK1433480T3 (da) | Lægemiddel indeholdende pyrimidin-derivat | |
| EP1464636A4 (de) | Neue substanz mit antitumorwirkung/entzündungshemmender wirkung | |
| GEP20084394B (en) | Novel intermediate for the preparation of therapeutically active imidazopyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20231215 |